Legal Archives - Page 3 of 3 - Life Sciences Times

Beneath the biotech boom

April 17, 2025

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

April 17, 2025

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

THIS WEEK'S STORIES

Life Sciences M&A on the Rise: Deloitte Highlights Key Trends in Industry Restructuring, Divestments, and Innovation

April 12, 2025

Viatris Names Hemanth J. Varghese as Chief Strategy Officer

April 14, 2025

Optellum Partners with Bristol Myers Squibb to Advance AI-Driven Early Lung Cancer Diagnosis

April 15, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

Veteran Life Sciences Attorney Danielle Naftulin Joins Wilson Sonsini as Partner

Vizgen Reaches Settlement with 10x Genomics and Harvard University, Ending Multi-Jurisdictional Patent Dispute

Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of ‘781 Patent Owned by Exact Sciences

Most Read

Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine

Beneath the biotech boom

EDITOR PICKS

Beneath the biotech boom

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

THIS WEEK'S STORIES

Life Sciences M&A on the Rise: Deloitte Highlights Key Trends in Industry Restructuring, Divestments, and Innovation

Viatris Names Hemanth J. Varghese as Chief Strategy Officer

Optellum Partners with Bristol Myers Squibb to Advance AI-Driven Early Lung Cancer Diagnosis

POPULAR CATEGORY

ABOUT US

FOLLOW US